{"created_at":"Tue Apr 21 11:41:52 +0000 2015","id":590480567986102272,"id_str":"590480567986102272","text":"RT @AndyBiotech: Important for $MRK $AZN $RHHBY\n\nFDA will NOT require OS in lung for subsequent PD-1 even though $BMY Opdivo approved on OS\u2026","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":82095703,"id_str":"82095703","name":"Steven Dickman","screen_name":"cbtadvisors","location":"Cambridge, MA, USA","url":"http:\/\/bostonbiotechwatch.com","description":"Founder-CEO of CBT Advisors, a life sciences consultancy. Blogger. Former venture capitalist with TVM Capital, former reporter with Nature, The Economist.","protected":false,"verified":false,"followers_count":2669,"friends_count":1090,"listed_count":120,"favourites_count":1796,"statuses_count":5937,"created_at":"Tue Oct 13 13:36:28 +0000 2009","utc_offset":-18000,"time_zone":"Central Time (US & Canada)","geo_enabled":true,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/983366435\/megpix-030907-209_4x6_normal.jpg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/983366435\/megpix-030907-209_4x6_normal.jpg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Tue Apr 21 11:40:42 +0000 2015","id":590480275546607616,"id_str":"590480275546607616","text":"Important for $MRK $AZN $RHHBY\n\nFDA will NOT require OS in lung for subsequent PD-1 even though $BMY Opdivo approved on OS. via @BioCentury","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":573249824230916096,"in_reply_to_status_id_str":"573249824230916096","in_reply_to_user_id":632341632,"in_reply_to_user_id_str":"632341632","in_reply_to_screen_name":"AndyBiotech","user":{"id":632341632,"id_str":"632341632","name":"Andy Biotech","screen_name":"AndyBiotech","location":"","url":null,"description":"#Biotech Investor | Recovering Scientist | #RareDiseases Advocate | May have positions in mentioned names | Opinions are strictly my own","protected":false,"verified":false,"followers_count":11338,"friends_count":498,"listed_count":348,"favourites_count":4539,"statuses_count":12224,"created_at":"Tue Jul 10 19:50:09 +0000 2012","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C6E2EE","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_tile":false,"profile_link_color":"1F98C7","profile_sidebar_border_color":"C6E2EE","profile_sidebar_fill_color":"DAECF4","profile_text_color":"663B12","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000074240482\/d961ebeb9f4fe6b084a68663b9a36738_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000074240482\/d961ebeb9f4fe6b084a68663b9a36738_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":1,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"BioCentury","name":"BioCentury","id":227778014,"id_str":"227778014","indices":[128,139]}],"symbols":[{"text":"MRK","indices":[14,18]},{"text":"AZN","indices":[19,23]},{"text":"RHHBY","indices":[24,30]},{"text":"BMY","indices":[96,100]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"AndyBiotech","name":"Andy Biotech","id":632341632,"id_str":"632341632","indices":[3,15]},{"screen_name":"BioCentury","name":"BioCentury","id":227778014,"id_str":"227778014","indices":[139,140]}],"symbols":[{"text":"MRK","indices":[31,35]},{"text":"AZN","indices":[36,40]},{"text":"RHHBY","indices":[41,47]},{"text":"BMY","indices":[113,117]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1429616512663"}
{"created_at":"Tue Apr 21 12:00:02 +0000 2015","id":590485139760803840,"id_str":"590485139760803840","text":"$MRK:\n\nKeytruda By Merck &amp; Co., Inc. (NYSE:MRK) Is More Effective Than ...:\n\nhttp:\/\/t.co\/KyGvrqQYgD","source":"\u003ca href=\"http:\/\/www.stocknewswires.com\" rel=\"nofollow\"\u003eStockNewsWires\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2341445778,"id_str":"2341445778","name":"StockNewsWires","screen_name":"StockNewsWires","location":"United States","url":null,"description":"Invest like a fish","protected":false,"verified":false,"followers_count":317,"friends_count":9,"listed_count":52,"favourites_count":0,"statuses_count":104993,"created_at":"Thu Feb 13 05:31:52 +0000 2014","utc_offset":-10800,"time_zone":"Atlantic Time (Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C6E2EE","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_tile":false,"profile_link_color":"1F98C7","profile_sidebar_border_color":"C6E2EE","profile_sidebar_fill_color":"DAECF4","profile_text_color":"663B12","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/542238326397227008\/UfZ0ulTf_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/542238326397227008\/UfZ0ulTf_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/KyGvrqQYgD","expanded_url":"http:\/\/www.stocknewswires.com\/2015\/04\/mrk-keytruda-by-merck-co-inc-nysemrk-is-more-effective-than.html","display_url":"stocknewswires.com\/2015\/04\/mrk-ke\u2026","indices":[81,103]}],"user_mentions":[],"symbols":[{"text":"MRK","indices":[0,4]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1429617602659"}
